Compare LII & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LII | STE |
|---|---|---|
| Founded | 1895 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 25.9B |
| IPO Year | 1999 | 1992 |
| Metric | LII | STE |
|---|---|---|
| Price | $511.08 | $263.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $605.18 | $268.25 |
| AVG Volume (30 Days) | 451.7K | ★ 674.3K |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.02% | 0.96% |
| EPS Growth | 12.46 | ★ 59.39 |
| EPS | ★ 23.67 | 6.97 |
| Revenue | $5,345,300,000.00 | ★ $5,702,415,000.00 |
| Revenue This Year | N/A | $9.24 |
| Revenue Next Year | $7.34 | $6.30 |
| P/E Ratio | ★ $21.62 | $37.72 |
| Revenue Growth | 3.77 | ★ 7.08 |
| 52 Week Low | $443.19 | $200.98 |
| 52 Week High | $689.44 | $268.60 |
| Indicator | LII | STE |
|---|---|---|
| Relative Strength Index (RSI) | 60.54 | 59.06 |
| Support Level | $481.60 | $256.68 |
| Resistance Level | $499.95 | $268.60 |
| Average True Range (ATR) | 14.23 | 4.64 |
| MACD | 6.58 | -0.69 |
| Stochastic Oscillator | 99.78 | 65.59 |
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.